The biopharmaceutical industry is central to China's strategic goals, merging economic growth, public welfare, and national security. China shifts from producing generic drugs to innovating in life sciences, competing globally…
The Trump administration's proposed reduction in federal payments poses a significant threat to research universities like Virginia Tech, with potential losses reaching $18 million annually. Indirect costs, essential for maintaining…
The closure of a key CDC laboratory, initiated by the Trump administration, disrupts STI surveillance and the fight against drug-resistant strains, especially "super gonorrhea." The Gonococcal Isolate Surveillance Project (GISP),…
In 2024, biotech firms were responsible for nearly two-thirds of new drug approvals by the U.S. FDA. Smaller biotechs are increasingly choosing market independence, challenging traditional Big Pharma dominance. Advancements…
Genenta Science is set to present at the 'Montalcini Global Biotech Tour' in Doha on April 17th, 2025, aiming to expand investment opportunities beyond traditional western markets. The firm secured…
Biotechnology's infrastructure is crucial for innovation in health and agriculture but lacks adequate national security protection. The National Security Commission on Emerging Biotechnology urges classifying biotechnology alongside critical sectors like…
IO Biotech faces critical financial decisions as its cash reserves deplete, having $60 million at the start of December 2024 but burning $82 million annually. The company’s cash burn rate…
A surge in online search activity highlights growing investor interest in biotech companies. Biotie Therapies is at the forefront, focusing on transformative treatments for central nervous system disorders such as…
The global biotechnology race is intensifying, with the U.S. and China competing for dominance, impacting national security, economic balance, and technological progress. The National Security Commission on Emerging Biotechnology warns…
The U.S. is positioning itself as a leader in biotechnology through a strategic push championed by Senator Todd Young. Young's proposal suggests unifying various federal agencies to align under a…